In March 2018, Leidos amended the terms of its senior secured $1.1 billion Term Loan B.
Accumulated goodwill impairment losses were $369 million and $117 million included within the Health and Civil segments, respectively, at September 28, 2018, December 29, 2017, and December 30, 2016.
Effective the beginning of fiscal 2018, the Company established a new CAS structure and revised its disclosure statements accordingly to reflect the related cost accounting practice changes.
Also, during the quarter ended June 30, 2017, Leidos and Plainfield entered into an amendment to the Note allowing Plainfield to defer up to $4 million of the interest and principal payments due in July 2017 and January 2018 until July 2018.
As of September 28, 2018, and December 29, 2017, the fair value of debt was $3.1 billion and $3.2 billion, respectively, and the carrying amount was $3.0 billion and $3.1 billion, respectively (see "Note 14–Debt").
The Company has interest rate swap agreements to hedge the cash flows of a portion of its variable rate senior secured term loans (the "Variable Rate Loans").
The Company consolidates the financial results for MSA into its unaudited condensed consolidated financial statements.
The Company's derivatives consisted of the fair value interest rate swaps on its $450 million, fixed rate 4.45% senior secured notes maturing in December 2020 and cash flow interest rate swaps on $1.5 billion of the Company's variable rate senior secured term loans (see "Note 13–Derivative Instruments").
Government spending levels for the DoD may be impacted by spending priorities as a result of competing demands for federal funds.
Under the terms of the interest rate swap agreements, the Company will receive semi-annual interest payments at the coupon rate of 4.45% and will pay variable interest based on the six-month LIBOR rate.
The Company's contracts with the U.S. government often contain options to renew existing contracts for an additional period of time (generally a year at a time) under the same terms and conditions as the original contract, and generally do not provide the customer any material rights under the contract.
The decrease in unbilled receivables was primarily due to the timing of billings and revenue recognized on certain contracts.Each contract is competitively priced and bid separately.
At September 28, 2018, and December 29, 2017, we had outstanding debt of $3.0 billion and $3.1 billion, respectively.
All were funded at increased levels from the previous year.
The increase in revenues for the three months ended September 28, 2018, as compared to the three months ended September 29, 2017, was primarily attributable to new awards and timing of revenue recognition on certain contracts, partially offset by the completion of certain contracts.
For the next 12 months, we anticipate that we will be able to meet our liquidity needs, including servicing our debt, through cash generated from operations, available cash balances and, if needed, borrowings from our revolving credit facility.Exhibits.